Advicenne S.A. (ADVIC.PA)
6.5 €
0.00 (0.00%)
Rating:
Recommendation:
-
| Symbol | ADVIC.PA |
|---|---|
| Price | 6.5 € |
| Beta | 1.432 |
| Volume Avg. | 0.05M |
| Market Cap | - |
| Shares () | - |
| 52 Week Range | 6.07-6.62 |
| 1y Target Est | - |
| DCF Unlevered | ADVIC.PA DCF -> | |
|---|---|---|
| DCF Levered | ADVIC.PA LDCF -> | |
| ROE | -58.92% | Strong Sell |
| ROA | -59.84% | Strong Sell |
| Operating Margin | - | |
| Debt / Equity | 2.65% | Neutral |
| P/E | -3.67 | Strong Sell |
| P/B | 3.14 | Strong Buy |
About
Download (Excel)Advicenne S.A. develops therapeutics for the treatment of rare kidney diseases. Its lead product candidate is ADV7103 for the treatment of distal renal tubular acidosis in children and adults, as well as for the treatment of cystinuria, an inherited renal tubulopathy. The company also provides ADV6209, an oral liquid solution for children to reduce anxiety and to improve their immobility. Advicenne S.A. was founded in 2007 and is based in Paris, France.